Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT5001 in Hemodialysis Patients with Uremic Pruritus
NCT04393675Phase 2Terminated
- Sponsor
- Lumosa Therapeutics
- Start
- May 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LT-5001 in uremic pruritus, sponsored by Lumosa Therapeutics. Started May 2020; status: terminated.
02
Drugs
LT-5001
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT04393675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04393675.